Vita 34 AG
XETRA:V3V
Vita 34 AG
Revenue
Vita 34 AG
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Vita 34 AG
XETRA:V3V
|
Revenue
€74.9m
|
CAGR 3-Years
56%
|
CAGR 5-Years
29%
|
CAGR 10-Years
19%
|
|
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
Revenue
€19.5B
|
CAGR 3-Years
3%
|
CAGR 5-Years
3%
|
CAGR 10-Years
6%
|
F
|
Fresenius SE & Co KGaA
XETRA:FRE
|
Revenue
€22.3B
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
1%
|
E
|
Euroeyes International Eye Clinic Ltd
HKEX:1846
|
Revenue
HK$714.3m
|
CAGR 3-Years
15%
|
CAGR 5-Years
15%
|
CAGR 10-Years
N/A
|
Synlab AG
XETRA:SYAB
|
Revenue
€2.6B
|
CAGR 3-Years
0%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Vita 34 AG's Revenue?
Revenue
74.9m
EUR
Based on the financial report for Sep 30, 2023, Vita 34 AG's Revenue amounts to 74.9m EUR.
What is Vita 34 AG's Revenue growth rate?
Revenue CAGR 10Y
19%
Over the last year, the Revenue growth was -4%. The average annual Revenue growth rates for Vita 34 AG have been 56% over the past three years , 29% over the past five years , and 19% over the past ten years .